Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes

被引:23
|
作者
Fitch, Ken [1 ]
机构
[1] Univ Western Australia, Fac Life Sci, Sch Sports Sci Exercise & Hlth, Crawley, WA 6009, Australia
关键词
Olympic games; doping; anabolic steroids; erythropoietin; therapeutic use; TESTOSTERONE;
D O I
10.7861/clinmedicine.12-3-257
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Athletes have always sought to outperform their competitors and regrettably some have resorted to misuse of drugs or doping to achieve this. Stimulants were taken by the first Olympic athletes to be disqualified in 1972. Although undetectable until 1975, from the 1950s androgenic anabolic steroids were administered for increased strength and power followed in the 1990s by erythropoietin for enhanced endurance. Both are highly effective doping agents. As analytical science validated improved techniques to identify these drugs, Olympic athletes, including many medallists were caught and disqualified. When the International Olympic Committee (IOC) prohibited beta blockers (beneficial in shooting), diuretics (assist weight classified athletes) and glucocorticosteroids, some athletes with genuine medical conditions were denied legitimate medical therapy. To overcome this, in 1992 the IOC introduced a system known now as Therapeutic Use Exemption (TUE). This paper discusses Olympic athletes who have been known to dope at past Games and some medical indications and pitfalls in the TUE process.
引用
收藏
页码:257 / 260
页数:4
相关论文
共 50 条
  • [1] Comparative study of the medication use by athletes in Olympic and Paralympic Games in Athens and their implications in doping control
    Jamurtas, Athanasios
    Tsiokanos, Athanasios
    PapalexiS, Petros
    Tsitsimpikou, Christina
    TOXICOLOGY LETTERS, 2008, 180 : S29 - S29
  • [2] Hospital use by Olympic athletes during the 1996 Atlanta Olympic Games
    Keim, ME
    Williams, D
    MEDICAL JOURNAL OF AUSTRALIA, 1997, 167 (11-12) : 603 - 605
  • [3] Women athletes in the Olympic Games
    Nunes, Rita Amaral
    JOURNAL OF HUMAN SPORT AND EXERCISE, 2019, 14 (03): : 674 - 683
  • [4] Medication Use by Athletes at the Athens 2004 Summer Olympic Games
    Tsitsimpikou, Christina
    Tsiokanos, Athanasios
    Tsarouhas, Konstantinos
    Schamasch, Patrick
    Fitch, Kenneth D.
    Valasiadis, Dimitrios
    Jamurtas, Athanasios
    CLINICAL JOURNAL OF SPORT MEDICINE, 2009, 19 (01): : 33 - 38
  • [5] ADMINISTRATORS VIEW OF USE AND MISUSE OF DRUGS AMONG ATHLETES
    SMITH, JC
    JOURNAL OF SCHOOL HEALTH, 1972, 42 (03) : 170 - 171
  • [6] Blood doping at the Olympic Games
    Fitch, Kenneth D.
    JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2017, 57 (11): : 1526 - 1532
  • [7] The Athletes' Voice and a Feminist Ethics of Care: The Russian Doping Scandal at the 2016 Olympic Games
    Gonsalves, Mikael
    Schneider, Angela J.
    INTERNATIONAL JOURNAL OF THE HISTORY OF SPORT, 2021, 38 (10-11): : 1122 - 1144
  • [8] Use of Supplements by Japanese Elite Athletes for the 2012 Olympic Games in London
    Sato, Akiko
    Kamei, Akiko
    Kamihigashi, Etsuko
    Dohi, Michiko
    Akama, Takao
    Kawahara, Takashi
    CLINICAL JOURNAL OF SPORT MEDICINE, 2015, 25 (03): : 260 - 269
  • [9] Education Strategies Intended to Prevent Doping Use among Olympic Athletes
    Andreiasu, I. G.
    Vajiala, G. E.
    Popescu, R. A.
    Butoi, A.
    Gutul, A., V
    RETHINKING SOCIAL ACTION. CORE VALUES, 2015, : 59 - 62
  • [10] Mortality of Japanese Olympic athletes in 1964 Tokyo Olympic Games
    Takeuchi, Taro
    Kitamura, Yuri
    Ishizuka, Soya
    Yamada, Sachiko
    Aono, Hiroshi
    Kawahara, Takashi
    Sobue, Tomotaka
    BMJ OPEN SPORT & EXERCISE MEDICINE, 2021, 7 (01):